cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Axogen Inc
6 own
6 watching
Current Price
$18.24
$-0.01
(-0.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
570.66M
52-Week High
52-Week High
18.49000
52-Week Low
52-Week Low
5.55000
Average Volume
Average Volume
1.3M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization570.66M
icon52-Week High18.49000
icon52-Week Low5.55000
iconAverage Volume1.3M
iconDividend Yield--
iconP/E Ratio--
What does the Axogen Inc do?
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Read More
How much money does Axogen Inc make?
News & Events about Axogen Inc.
Ticker Report
1 year ago
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. Several other brokerages also recently weighed in on AXGN. JMP Securities reaffirmed a market outperform rating and set a $20.00 target price on shares of AxoGen...
Zolmax
1 year ago
JMP Securities reiterated their market outperform rating on shares of AxoGen (NASDAQ:AXGN Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. JMP Securities currently has a $20.00 price objective on the medical equipment providers stock. Separately, StockNews.com ...
Globe Newswire
2years ago
ALACHUA, Fla. and TAMPA, Fla., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2022 revenue. Preliminary ...
Globe Newswire
2years ago
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including over 1,500 nerve repairs across 35 studiesALACHUA, Fla. and TAMPA, Fla., Jan. 05, 2023 (GLOBE ...
Globe Newswire
2years ago
ALACHUA, Fla. and TAMPA, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Bri Majsiak, a Resensation patient, has been selected to ride on the 2023 Donate...
Frequently Asked Questions
Frequently Asked Questions
What is Axogen Inc share price today?
plus_minus_icon
Can Indians buy Axogen Inc shares?
plus_minus_icon
How can I buy Axogen Inc shares from India?
plus_minus_icon
Can Fractional shares of Axogen Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Axogen Inc stocks?
plus_minus_icon
What is today’s traded volume of Axogen Inc?
plus_minus_icon
What is today’s market capitalisation of Axogen Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Axogen Inc?
plus_minus_icon
What percentage is Axogen Inc down from its 52-Week High?
plus_minus_icon
What percentage is Axogen Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$18.24
$-0.01
(-0.05%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Inari Medical Inc
Inari Medical Inc
$79.30
$-0.04 (-0.05 %)
bluebird bio, Inc.
bluebird bio, Inc.
$8.03
$-0.46 (-5.42 %)
CEL-SCI Corp
CEL-SCI Corp
$0.41
$-0.00 (-0.27 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$1.25
$-0.03 (-2.71 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Inari Medical Inc
Inari Medical Inc
$79.30
$-0.04 (-0.05 %)
bluebird bio, Inc.
bluebird bio, Inc.
$8.03
$-0.46 (-5.42 %)
CEL-SCI Corp
CEL-SCI Corp
$0.41
$-0.00 (-0.27 %)
Fate Therapeutics Inc
Fate Therapeutics Inc
$1.25
$-0.03 (-2.71 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00